The pharmaceutical industry translated a wonky policy topic into a talking point repeated by a range of groups.

President Donald Trump will announce a plan to lower U.S. prescription drug costs by tying the amount the government pays for ...

Consumers, doctors and other advocates agree pharmacy benefit managers (PBMs) wield too much power and influence over patients’ access to medicines and their prices.

CHARLOTTE, N.C. — A bill advancing through the North Carolina General Assembly this week could significantly impact ...

In a lawsuit against St. Louis-based Express Scripts and Eagan, Minn,-based Prime Therapeutics in U.S. District Court in ...

From the column: "In Minnesota, the Legislature has a lot of power to effect change for Medical Assistance patients." ...

On April 16, Cramer commented: “I always talk to you about the drug middlemen. Companies like McKesson and Cencora, these are two money machines no matter what. Even as I believe we should be ...

IN RURAL New Hampshire, we take pride in knowing and caring for our neighbors. At Ammonoosuc Community Health Services (ACHS) ...

The use of preferred pharmacy networks tripled to 44% among Medicare Advantage drug plans over the past ... D networks maintained by drug benefits middlemen were much more likely to close over ...

When President Trump signed an executive order this month to try to reduce drug prices ... together a report “re-evaluating the role of middlemen,” who have been the target of one of the ...